Sotera Health sterilizes medical devices and tests products for safety—think of it as the invisible gatekeeper ensuring your pacemaker or syringe is germ-free before it reaches a hospital.
Sterilization services drive revenue, with annual sales growing from USD 1.05B to USD 1.16B over three years. Gross margins hover around 55%, and operating margins improved to 33.75% in 2025, indicating recurring, high-margin contract work.
Regulatory approvals and long-term contracts with medical device giants like Medtronic and Abbott create switching costs, but ethylene oxide emission concerns and potential regulatory tightening could erode this advantage.
Key events, in time order
Q2 revenue and EPS beat estimates, reinforcing fundamentals
None yet
None yet
No comments yet.
Facts and opinions separated · All items sourced · Not investment advice
